Fiera Milano

Italy   8 – 10/10/2024

IASIS PHARMA participated with great success at the Global Exhibition of the Pharmaceutical industry, CPhI.

The 34th edition of CPHI Worldwide took place at the Fiera Milano from 8-10 October 2024.

The organizers registered thousands of visitors and over 2,000 exhibitors, while hundreds were the professionals of the pharmaceutical industry who visited the IASIS PHARMA exhibition stand, receiving interesting information about the company’s unique and wide product portfolio.

More specifically, the company exhibited:

• IASIS PHARMA’sleading position in the Nitrofurantoin market, presenting the product in four (4) pharmaceutical formulations: IR tablets, IR capsules, PR capsules, oral suspension, with 36 MAs (Marketing Authorizations) in 23 countries.
• Its specialization in Contract Manufacturing Services in its 4 new, state-of-the-art production facilities.
• The wide range of prescription drugs in the form of effervescent tablets.
• An extremely interesting range of new products in Oral Suspension formin niche markets – New Product Pipeline.
• The facility that covers a large range of creams, gels and ointments, applying certified methods to ensure GMP & GLP standards.

IASIS PHARMA presented audio-visual material about the company’s new, state-of-the-art production facilities in Koropi, Attica.

During the three-day event, the IASIS PHARMA Management team succeeded in further strengthening its international partnerships as well as laying the foundations for new ones, further strengthening the company’s international presence.

Finally, after its successful participation in CPhI Fiera Milano 2024, IASIS PHARMA has already started prepared for the next CPhI on 28 – 30/10/2025 at Messe Frankfurt in Germany.

EXPECT MORE…